《健康保险流通与责任法案》非歧视规定概述。
An overview of the HIPAA nondiscrimination regulation.
作者信息
Nielsen M C
机构信息
Washington, DC, Law Firm of Feder Semo Clark & Bard, PC, USA.
出版信息
Manag Care Interface. 2001 Dec;14(12):59-62.
PMID:11794844
Abstract
The nondiscrimination regulation requires that MCOs carefully review the terms of their plans and contracts to ensure that eligibility and benefits are not tied to any enumerated health factors and that wellness programs comply with proposed rules.
摘要
非歧视规定要求管理式医疗组织（MCOs）仔细审查其计划和合同条款，以确保资格和福利不与任何列举的健康因素挂钩，且健康计划符合拟议规则。
相似文献
1
An overview of the HIPAA nondiscrimination regulation.《健康保险流通与责任法案》非歧视规定概述。
Manag Care Interface. 2001 Dec;14(12):59-62.
2
3
Penalties, incentives and wellness programs after HIPAA.《健康保险流通与责任法案》后的处罚、激励措施及健康计划。
Empl Benefits J. 1999 Mar;24(1):29-32.
5
Realizing HIPAA benefits requires organizational change.实现《健康保险流通与责任法案》的益处需要组织变革。
Healthc Financ Manage. 2001 Oct;55(10):98-9.
6
Health insurance and the Genetic Information Nondiscrimination Act of 2008: implications for public health policy and practice.医疗保险与2008年《基因信息非歧视法案》：对公共卫生政策与实践的影响
Public Health Rep. 2009 Mar-Apr;124(2):328-31. doi: 10.1177/003335490912400222.
7
Converting interim HIPAA fixes into long-term strategies. HIPAA still represents an opportunity for MCOs to strengthen their financial efficiency, but only if they employ a strategic approach.将临时的《健康保险流通与责任法案》修复措施转化为长期战略。《健康保险流通与责任法案》对管理式医疗组织（MCOs）而言仍是一个提升财务效率的契机，但前提是它们要采用战略方法。
Health Manag Technol. 2003 Oct;24(10):36-8, 40-1.
8
Wellness programs and lifestyle discrimination--the legal limits.健康计划与生活方式歧视——法律界限
N Engl J Med. 2008 Jul 10;359(2):192-9. doi: 10.1056/NEJMhle0801929.
9
State regulation of private health insurance: prescription drug benefits, experimental treatments, and consumer protection.私人医疗保险的国家监管：处方药福利、实验性治疗与消费者保护。
Am J Manag Care. 2002 Nov;8(11):977-85.
10
HIPAA security requirements.《健康保险流通与责任法案》安全要求。
Healthplan. 2003 Jan-Feb;44(1):28-31.
Zotero 插件